Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
8.15
-0.43 (-5.01%)
Jun 27, 2025, 4:00 PM - Market closed
Cybin Market Cap
Cybin has a market cap or net worth of $171.44 million as of June 27, 2025. Its market cap has decreased by -34.57% in one year.
Market Cap
171.44M
Enterprise Value
76.72M
1-Year Change
-34.57%
Ranking
Category
Stock Price
$8.15
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $171.44M, an increase of 88.20%. That is a compound annual growth rate of 14.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 166.18M | -5.80% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |